Parsortix
Showing 1 - 8 of 8
Circulating Tumor Cells in High Risk and Early Metastatic
Recruiting
- High Risk Prostate Carcinoma
- +3 more
- Blood collection
-
Bala-Cynwyd, Pennsylvania
- +1 more
Jun 28, 2022
EMT on CTCs and Disease Progression in Prostate Cancer
Active, not recruiting
- Prostate Cancer
- CellSearch CTC platform
- Parsortix CTC platform
-
London, Ontario, CanadaLondon Regional Cancer Program
Mar 5, 2022
Harvest of CTCs From MBC Patients Using Parsortix™ PC1 System
Completed
- Healthy Volunteers
- Breast Cancer, Metastatic
- Blood draw
-
Los Angeles, California
- +3 more
Oct 1, 2020
Lung Cancer Trial in Toulouse (Blood samples will be collected at two times before the treatment initiation:)
Not yet recruiting
- Lung Cancer
- Blood samples will be collected at two times before the treatment initiation:
-
Toulouse, France
- +1 more
Aug 3, 2023
Estimate Risk of Cancer in Gynecology Patients Presenting
Completed
- Ovarian Neoplasms
- Pelvic imaging
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center Wilmot Cancer Institute
Jun 27, 2022
Blood Markers of Tumor Dissemination in Versus Without
Not yet recruiting
- Colorectal Cancer
- +2 more
- Blood test
-
Nîmes, FranceCHU de Nîmes
Dec 5, 2022
Estimate Risk of Ovarian Cancer in Patients With a Pelvic Mass.
Completed
- Ovarian Neoplasms
- Pelvic imaging
- +2 more
-
Vienna, Austria
- +4 more
Nov 8, 2018
Non Small Cell Lung Cancer Trial in Athens (blood sampling)
Unknown status
- Non Small Cell Lung Cancer
- blood sampling
-
Athens, Attica, Greece
- +5 more
Dec 7, 2018